Cite
Maruani A, Tavernier E, Boccara O, et al. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial. JAMA Dermatol. 2021;157(11):1289-1298doi: 10.1001/jamadermatol.2021.3459.
Maruani, A., Tavernier, E., Boccara, O., Mazereeuw-Hautier, J., Leducq, S., Bessis, D., Guibaud, L., Vabres, P., Carmignac, V., Mallet, S., Barbarot, S., Chiaverini, C., Droitcourt, C., Bursztejn, A. C., Lengellé, C., Woillard, J. B., Herbreteau, D., Le Touze, A., Joly, A., Léauté-Labrèze, C., Powell, J., Bourgoin, H., Gissot, V., Giraudeau, B., & Morel, B. (2021). Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial. JAMA dermatology, 157(11), 1289-1298. https://doi.org/10.1001/jamadermatol.2021.3459
Maruani, Annabel, et al. "Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial." JAMA dermatology vol. 157,11 (2021): 1289-1298. doi: https://doi.org/10.1001/jamadermatol.2021.3459
Maruani A, Tavernier E, Boccara O, Mazereeuw-Hautier J, Leducq S, Bessis D, Guibaud L, Vabres P, Carmignac V, Mallet S, Barbarot S, Chiaverini C, Droitcourt C, Bursztejn AC, Lengellé C, Woillard JB, Herbreteau D, Le Touze A, Joly A, Léauté-Labrèze C, Powell J, Bourgoin H, Gissot V, Giraudeau B, Morel B. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial. JAMA Dermatol. 2021 Nov 01;157(11):1289-1298. doi: 10.1001/jamadermatol.2021.3459. PMID: 34524406; PMCID: PMC8444064.
Copy
Download .nbib